Martin Wartenberg

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Journal: Cell reports

Published: May 19, 2026

Odontogenic Keratocyst in the Anterior Maxilla: A Case Report

Odontogenic Keratocyst in the Anterior Maxilla: A Case Report

Journal: Swiss dental journal

Published: March 11, 2026

Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetry.

Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetry.

Journal: IEEE transactions on bio-medical engineering

Published: February 04, 2026

Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies.

Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies.

Journal: Journal of translational autoimmunity

Published: December 06, 2025

A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiology.

A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiology.

Journal: Science translational medicine

Published: November 05, 2025

A Central Giant Cell Granuloma: A case report

A Central Giant Cell Granuloma: A case report

Journal: Swiss dental journal

Published: September 23, 2025

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Journal: Cell reports

Published: May 19, 2025

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.

Journal: BMC cancer

Published: April 22, 2025

Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma.

Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma.

Journal: Journal of gastroenterology

Published: February 19, 2025

Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Journal: British journal of cancer

Published: February 13, 2025

TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.

TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.

Journal: Molecular therapy. Oncology

Published: November 21, 2024

Non-specific presentation of metastatic small bowel adenocarcinoma with diagnostic challenges.

Non-specific presentation of metastatic small bowel adenocarcinoma with diagnostic challenges.

Journal: BMJ case reports

Published: August 30, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026